BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 5458402)

  • 1. Potential antineoplastics. V. Synthesis of ethyl 2,3-dioxobutyrate 2-arylhydrazono-3-thiosemicarbazones.
    Garg HG; Sharma RA
    J Med Chem; 1970 Sep; 13(5):991-2. PubMed ID: 5458402
    [No Abstract]   [Full Text] [Related]  

  • 2. Heterocyclic thiosemicarbazones and related derivatives. Synthesis and screening data.
    Giner-Sorolla A; McCravey M; Longley-Cook J; Burchenal JH
    J Med Chem; 1973 Sep; 16(9):984-8. PubMed ID: 4745514
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential antitumor agents. 5. Methylated -(N)-heterocyclic carboxaldehyde thiosemicarbazones.
    Agrawal KC; Cushley RJ; Lipsky SR; Wheaton JR; Sartorelli AC
    J Med Chem; 1972 Feb; 15(2):192-5. PubMed ID: 5008241
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential antitumor agents. IV. 4-substituted 1-formylisoquinoline thiosemicarbazones.
    Agrawal KC; Cushley RJ; McMurray WJ; Sartorelli AC
    J Med Chem; 1970 May; 13(3):431-4. PubMed ID: 5466487
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and antitumor activity of 3- and 5-hydroxy-4-methylpyridine-2-carboxaldehyde thiosemicarbazones.
    Wang Y; Liu MC; Lin TS; Sartorelli AC
    J Med Chem; 1992 Oct; 35(20):3667-71. PubMed ID: 1433177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinostatic activity of thiosemicarbazones of formyl heteroaromatic compounds. VII. 2-Formylpyridine derivatives bearing additional ring substituents.
    Blanz EJ; French FA; DoAmaral JR; French DA
    J Med Chem; 1970 Nov; 13(6):1124-30. PubMed ID: 5273758
    [No Abstract]   [Full Text] [Related]  

  • 7. Alpha-(N)-formylheteroaromatic thiosemicarbazones. Inhibition of tumor-derived ribonucleoside diphosphate reductase and correlation with in vivo antitumor activity.
    French FA; Blanz EJ; Shaddix SC; Brockman RW
    J Med Chem; 1974 Feb; 17(2):172-81. PubMed ID: 4809253
    [No Abstract]   [Full Text] [Related]  

  • 8. Carcinostatic activity of thiosemicarbazones of formyl heteroaromatic compounds. VI. 1-Formylisoquinoline derivatives bearing additional ring substituents, with notes on mechanism of action.
    French FA; Blanz EJ; DoAmaral JR; French DA
    J Med Chem; 1970 Nov; 13(6):1117-24. PubMed ID: 5273757
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and antitumor activity of amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone.
    Liu MC; Lin TS; Sartorelli AC
    J Med Chem; 1992 Oct; 35(20):3672-7. PubMed ID: 1433178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The synthesis and biologic activity of analogs of 1,4-benzoquinone-guanylhydrazone-thiosemicarbazone. 2. Substitution at the quinone ring by alkyl groups].
    Schulze W; Gutsche W; Wohlrabe K; Tresselt D; Horn G; Fleck W
    Pharmazie; 1986 Feb; 41(2):99-101. PubMed ID: 3725863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antitumor activity of 4- and 5-substituted derivatives of isoquinoline-1-carboxaldehyde thiosemicarbazone.
    Liu MC; Lin TS; Penketh P; Sartorelli AC
    J Med Chem; 1995 Oct; 38(21):4234-43. PubMed ID: 7473550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of 4-(p-(bis(2-chloroethyl)amino)phenyl)butyramides as potential antitumor agents. I.
    Billman JH; Roehrig GR
    J Pharm Sci; 1974 Sep; 63(9):1487-9. PubMed ID: 4427280
    [No Abstract]   [Full Text] [Related]  

  • 13. Kethoxal bis(thiosemicarbazone). I. Effects against experimental tumors.
    Mihich E; Nichol CA
    Cancer Res; 1965 Oct; 25(9):1410-6. PubMed ID: 5217028
    [No Abstract]   [Full Text] [Related]  

  • 14. [Compounds with antitumor activity. V. Hydrazone derivatives of 5-formylimidazo(2,1-b)thiazoles and 6-substituted 2,3-dihydro-5-formylimidazo(2,1-b)thiazoles].
    Andreani A; Rambaldi M; Bonazzi D
    Farmaco Sci; 1980 Jul; 35(7):573-80. PubMed ID: 7450046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 5,6-dihydro-8(7H)-quinolinone thiosemicarbazones as potential antitumor agents.
    Lemke TL; Shek TW; Cates LA; Smith LK
    J Med Chem; 1977 Oct; 20(10):1351-4. PubMed ID: 333114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aryl-2-halogenoalkylamines. XXII. Derivatives of phenoxyacetic acid: synthesis and antineoplastic activities.
    Artico M; Ross WC
    Biochem Pharmacol; 1968 Jun; 17(6):873-82. PubMed ID: 5661350
    [No Abstract]   [Full Text] [Related]  

  • 17. Aryl-2-halogenoalkylamines. 23. Derivatives of oxanilic acid and salicylic acid: synthesis and antineoplastic activities.
    Artico M; Ross WC
    Biochem Pharmacol; 1968 Jun; 17(6):883-91. PubMed ID: 5661351
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and antitumor activity of 4-[p-[bis(2-chloroethyl)amino]phenyl]butyrates.
    Roehrig GR; Billman JH; Marcec J; Fritz P; Shea F
    J Pharm Sci; 1980 Oct; 69(10):1232-4. PubMed ID: 7420301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Acetylpyridine thiosemicarbazones. 6.2-Acetylpyridine and 2-butyrylpyridine thiosemicarbazones as antileukemic agents.
    Klayman DL; Scovill JP; Mason CJ; Bartosevich JF; Bruce J; Lin AJ
    Arzneimittelforschung; 1983; 33(7):909-12. PubMed ID: 6684928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aryl-2-halogenoalkylamines. XXIV. Derivatives of o-, m- and p-aminophenol: synthesis and antineoplastic activities.
    Artico M; Ross WC
    Biochem Pharmacol; 1968 Jun; 17(6):893-8. PubMed ID: 5661352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.